Advertisement

The Elevated Plus Maze Test for Measuring Anxiety-Like Behavior in Rodents

  • Ann-Katrin Kraeuter
  • Paul C. Guest
  • Zoltán SarnyaiEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1916)

Abstract

The elevated plus maze test is used to measure anxiety-like behavior in rodents. It can be used to gain insight into conditions such as posttraumatic stress disorder (PTSD) and other conditions marked by anxious behavior. It can also be used as a component in screening of novel compounds for anxiolytic properties. This model is based on aversion to open spaces, which is seen as the animal spending more time in the enclosed arms of the maze. This chapter describes the steps necessary for setting up and conducting the test, along with interpretation of the results.

Key words

Behavior Anxiety Rodent Mouse Elevated plus maze Anxiolytic 

References

  1. 1.
    Sarnyai Z, Alsaif M, Bahn S, Ernst A, Guest PC, Hradetzky E et al (2011) Behavioral and molecular biomarkers in translational animal models for neuropsychiatric disorders. Int Rev Neurobiol 101:203–238CrossRefPubMedGoogle Scholar
  2. 2.
    Crawley JN (2004) Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment Retard Dev Disabil Res Rev 10(4):248–258CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Nestler EJ, Hyman SE (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13(10):1161–1169CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Kraeuter AK, Guest PC, Sarnyai Z (2018) Neuropsychiatric sequelae of early nutritional modifications: a Beginner’s guide to behavioral analysis. Methods Mol Biol 1735:403–420CrossRefPubMedGoogle Scholar
  5. 5.
    Handley SL, Mithani S (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ‘fear’-motivated behaviour. Naunyn Schmiedeberg’s Arch Pharmacol 327(1):1–5CrossRefGoogle Scholar
  6. 6.
    File SE (1987) The contribution of behavioural studies to the neuropharmacology of anxiety. Neuropharmacology 26(7B):877–886CrossRefPubMedGoogle Scholar
  7. 7.
    McGonigle P (2014) Animal models of CNS disorders. Biochem Pharmacol 87(1):140–149CrossRefPubMedGoogle Scholar
  8. 8.
    Ennaceur A, Chazot PL (2016) Preclinical animal anxiety research - flaws and prejudices. Pharmacol Res Perspect 4(2):e00223.  https://doi.org/10.1002/prp2.223CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Ann-Katrin Kraeuter
    • 1
    • 2
  • Paul C. Guest
    • 3
  • Zoltán Sarnyai
    • 1
    • 2
    Email author
  1. 1.Laboratory of Psychiatric Neuroscience, Australian Institute of Tropical Health and MedicineJames Cook UniversityTownsvilleAustralia
  2. 2.Discipline of Biomedicine, College of Public Health, Medicine and Veterinary SciencesJames Cook UniversityTownsvilleAustralia
  3. 3.Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of BiologyUniversity of Campinas (UNICAMP)CampinasBrazil

Personalised recommendations